Dr. Gulshan Sharma has once again earned national recognition for his leadership and innovation—but the story behind his sustained impact at UTMB is even more compelling. Discover how his vision continues to shape excellence in care and quality across the institution.

UTMB Police is inviting public input to help strengthen service quality and community trust. Explore how you can share your feedback.

“This is about more than weight loss,” said Dr. Matthew Mendoza, assistant director of Team Science at UTMB. “We are using therapies already available to accelerate discovery rather than waiting decades for new drugs. Our goal is to make healthy aging a reality sooner.”

UTMB is preparing to roll out Zebra mobile devices across inpatient units, bringing faster communication, greater mobility, and more efficient workflows to clinical teams.

UTHealth Houston and University of Texas Medical Branch at Galveston are leading the trial focusing on ibogaine treatment for addiction and associated conditions.

Every three months, one inpatient and one ambulatory unit will be recognized for exemplifying our commitment to compassion and excellence.

Subtle symptoms masked a serious heart issue, until advanced imaging uncovered the real cause and opened the door to lifesaving care.

The “downside” of losing weight quickly—from medication, surgery or diet alone—can affect your energy, strength, digestion, and long-term success.

UTMB Health specialists reveal how faint, easily overlooked heartbeat changes could point to hidden rhythm issues—and why early attention matters.

“It would have been hard, even five years ago, to predict that a drug that required regular injections, whose [side] effect is nausea and food avoidance, would have become so successful in a variety of areas, from weight loss to therapy for alcohol and drug addiction," said Catherine H. Schein, a professor in the department of Biochemistry and Molecular Biology.

UTMB specialists introduced a new system that tailors CT heart scans to the individual patient and minimizes radiation exposure.

UTMB is partnering with research leaders across the country to investigate a newly identified driver of aging—and to explore whether a targeted antiviral therapy could help extend health and independence later in life.

UTMB is now partnering with the City of Galveston as well as Buettner’s Blue Zone network of some 90 US cities, to study the physical and human ecology of Blue Zones.

Dr. Tina Wang, professor at The University of Texas Medical Branch (UTMB), has been elected to the American Academy of Microbiology’s 2026 class of Fellows.

Influenza D is better at replicating iin cells from human airways than the flu C virus. "The evidence of human infections is imperfect but fairly compelling,” says UTMB infectious disease clinician and epidemiologist Gregory Grey.

Researchers at The University of Texas Medical Branch have launched a study exploring whether an existing medication can actually slow the pace of biological aging. Early insights could help redefine what healthy aging looks like.

The UT System Board of Regents approved a $300 million expansion project at the UTMB Health League City Hospital Campus. It will bring new advanced diagnostic imaging capabilities for both inpatient and emergency settings, including MRI, CT, ultrasound, and fluoroscopy.

“Many supplements have real biologic effects, and when you layer them on top of blood thinners, you can tip into either bleeding or clotting without realizing it,” warns Dr. Joseph Allencherril, MD, a cardiologist with UTMB’s Department of Cardiovascular Medicine.

A healthier future for Galveston begins this March as UTMB takes the lead on the Blue Zones Project, a multi-year initiative focused on reshaping the environments where people live, work, and gather. Discover what comes next for the community.

Advanced cardiac imaging cardiologist Esosa Odigie-Okon, MD shares her thoughts in an article that demystifies cholesterol-related numbers and explains which one matters the most.